Department of Medicine

Celdara Medical and UVM Professor of Medicine Jason Botten, Ph.D., have received a Phase II Small Business Technology Transfer grant from the National Institute of Allergy and Infectious Diseases that will support the ongoing development of therapeutic antibodies for the treatment of Hantavirus Cardiopulmonary Syndrome – a severe respiratory disease caused by rodent-borne hantaviruses.

(JUNE 14, 2023) Vermont Health Commissioner Mark Levine, M.D., Associate Professor of Emergency Medicine Daniel Wolfson, M.D., FACEP, and Research Assistant Professor of Psychiatry Heidi Melbostad, Ph.D., MFT, spoke to Seven Days about the state’s efforts to address opioid addiction.